The US Food and Drug Administration has updated its guidance for registering cosmetic manufacturing facilities and listing products under the Modernization of Cosmetics Regulation Act to include three new Q&A items that will provide clarification on the responsibilities of US agents, the use of a single identifier number for multiple facilities and the listing of samples and gifts within the regulation’s portal.
US FDA Updates MoCRA Registration Guidance To Answer Stakeholder Questions
FDA publishes an updated registration guidance in the Federal Register 12 December to answer outstanding questions by stakeholders, including whether a single FEI number can be used for multiple related facilities.
More from Compliance
• By
Single-use packaging producers obligated under Oregon’s Extended Producer Responsibility law who still haven’t registered with program facilitators will struggle at this point to meet the fast-approaching material-reporting deadline, but should nonetheless jump into the process, says EPR consultant Michael Washburn.
• By
Many small US and independent beauty brands are still unfamiliar with the Modernization of Cosmetics Regulation Act, as are owners of beauty brands based outside the US; the lack of education about the regulation is making many stakeholders at risk for non-compliance.
• By
FDA publishes an updated registration guidance in the Federal Register 12 December to answer outstanding questions by stakeholders, including whether a single FEI number can be used for multiple related facilities.
• By
The Washington State Department of Ecology will take interim policy action by 1 January, 2025 that will provide manufacturers alternative paths to compliance with the 1ppm lead limit under the state’s Toxic Free Cosmetics Act, the agency announces. It also anticipates opening a rulemaking related to lead impurities in cosmetics in 2025.
More from HBW Insight
• By
Jump in cough & cold sales at the end of the year helps Recordati post higher OTC revenues for 2024.
• By
Changes established in West Virginia and proposed in numerous other states gained momentum after Trump was elected to his second term as president and nominated Kennedy to head HHS.
• By
Personal care companies selling in California that suspect they are subject to its listing of a common stabilizer and packaging material should collect Certificates of Analysis for all raw materials, pursue third-party formula testing and retain counsel.